The Latest Breaking News from LMND

Lemonade stock soars as the AI-powered insurance firm reports a strong Q3 and raises future guidance. Here’s why LMND shares are worth buying into the post-earnings strength.

Lemonade (NYSE: LMND) is up more than 60% year to date and consolidating just below its 52-week high, setting up a potential breakout ahead of its Q3 earnings.

Take homme/femme fashion to the next level

The insurance sector illustrates significant potential, particularly within the property and casualty segment. Given this backdrop, let us ascertain which insurance stocks among Lemonade (LMND), Berkshire Hathaway (BRK.B), and Old Republic International (ORI) are worth buying, selling, or holding. Read on….

High inflation and rate hikes are gulping away the insurance industry’s profit. Moreover, recessionary fears following the turmoil in the banking sector have dampened the industry’s prospects this year. Hence, it could be wise to avoid fundamentally weak insurance stocks Lemonade (LMND), Hippo Holdings (HIPO), and Maiden Holdings (MHLD). Read…

Although insurance companies benefit from rising interest rates, Lemonade (LMND) failed to surpass the consensus EPS estimate in the last reported quarter. Analysts expect its EPS to remain negative in fiscal 2022 and 2023. So, will LMND be able to turn around in this rising interest rate environment? Read on…

Lemonade (LMND) has been a post-IPO disappointment, but a unique joining of AI and insurance could produce a long-term winner.

Within the last quarter, Lemonade (NYSE:LMND) has observed the following analyst ratings:

Today I'll analyze Lemonade (LMND) and Root (ROOT) to determine which insurance stock is a better buy.